Literature DB >> 19438593

c-Src tyrosine kinase co-associates with and phosphorylates signal transducer and activator of transcription 5b which mediates the proliferation of normal human B lymphocytes.

M-P Cayer1, M Proulx, X-Z Ma, D Sakac, J-F Giguère, M Drouin, S Néron, D R Branch, D Jung.   

Abstract

c-Src is the normal human cellular protein homologue of the viral oncogene v-src. c-Src activity was reported recently to increase in CD40-activated human B lymphocytes, suggesting its involvement in proliferation. To elucidate the exact role of c-Src in this process, we investigated the effects of c-Src over-expression on normal B lymphocyte growth. B lymphocytes purified from human peripheral blood were infected with Ad5/F35 vector encoding either a constitutively active c-Src (c-Src/dominant-positive) or a dominant-negative c-Src (c-Src/DN). Little variation of B lymphocytes expansion could be observed between control enhanced yellow fluorescent protein and c-Src/dominant-positive-infected cells. In contrast, over-expression of c-Src/DN results in a 40% inhibition of B lymphocyte expansion. These results suggest that DN c-Src may compete with endogenous c-Src, resulting in partial inhibition of a transcriptional pathway involved in B lymphocyte proliferation. We demonstrate further that c-Src can phosphorylate signal transducer and activator of transcription 5b (STAT5b) on tyrosine 699 and that c-Src and STAT5b co-associate during B lymphocyte proliferation. These results confirm an important role for c-Src in the expansion of normal human B lymphocytes in vitro, in which c-Src may regulate STAT5b in the intracellular signalling pathway important for the proliferation of normal human B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438593      PMCID: PMC2691969          DOI: 10.1111/j.1365-2249.2009.03917.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.

Authors:  Y Okutani; A Kitanaka; T Tanaka; H Kamano; H Ohnishi; Y Kubota; T Ishida; J Takahara
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

2.  Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector Ad5/F35.

Authors:  Daniel Jung; Sonia Néron; Mathieu Drouin; Annie Jacques
Journal:  J Immunol Methods       Date:  2005-09       Impact factor: 2.303

Review 3.  Jaks and STATs: biological implications.

Authors:  W J Leonard; J J O'Shea
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

Review 4.  A model B-cell superantigen and the immunobiology of B lymphocytes.

Authors:  Gregg J Silverman; Carl S Goodyear
Journal:  Clin Immunol       Date:  2002-02       Impact factor: 3.969

Review 5.  STATs in oncogenesis.

Authors:  T Bowman; R Garcia; J Turkson; R Jove
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

6.  Mechanisms of protein A superantigen-induced signal transduction for proliferation of mouse B cell.

Authors:  T Das; G Sa; P K Ray
Journal:  Immunol Lett       Date:  1999-10-01       Impact factor: 3.685

7.  B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.

Authors:  R Ivanov; T Aarts; A Hagenbeek; S Hol; S Ebeling
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

8.  STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.

Authors:  Michael T Kloth; Kristen K Laughlin; Jacqueline S Biscardi; Julie L Boerner; Sarah J Parsons; Corinne M Silva
Journal:  J Biol Chem       Date:  2002-11-11       Impact factor: 5.157

9.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Authors:  R Garcia; T L Bowman; G Niu; H Yu; S Minton; C A Muro-Cacho; C E Cox; R Falcone; R Fairclough; S Parsons; A Laudano; A Gazit; A Levitzki; A Kraker; R Jove
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

10.  The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.

Authors:  A Lischke; R Moriggl; S Brändlein; S Berchtold; W Kammer; W Sebald; B Groner; X Liu; L Hennighausen; K Friedrich
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

View more
  1 in total

1.  Overexpression of PAX5 induces apoptosis in multiple myeloma cells.

Authors:  Maryse Proulx; Marie-Pierre Cayer; Mathieu Drouin; André Laroche; Daniel Jung
Journal:  Int J Hematol       Date:  2010-09-30       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.